Wall Street analysts forecast that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will announce $0.81 earnings per share (EPS) for the current quarter, according to Zacks. Nine analysts have made estimates for DENTSPLY SIRONA’s earnings, with the lowest EPS estimate coming in at $0.80 and the highest estimate coming in at $0.82. DENTSPLY SIRONA posted earnings per share of $0.67 during the same quarter last year, which would indicate a positive year-over-year growth rate of 20.9%. The company is expected to issue its next quarterly earnings report on Friday, February 23rd.
On average, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.65 per share for the current fiscal year, with EPS estimates ranging from $2.64 to $2.67. For the next fiscal year, analysts expect that the firm will post earnings of $2.89 per share, with EPS estimates ranging from $2.80 to $3.00. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that that provide coverage for DENTSPLY SIRONA.
XRAY has been the subject of a number of analyst reports. TheStreet upgraded shares of DENTSPLY SIRONA from a “c” rating to a “b-” rating in a research report on Friday, November 3rd. Stifel Nicolaus upped their price objective on shares of DENTSPLY SIRONA from $66.00 to $70.00 and gave the stock a “buy” rating in a research report on Monday, November 6th. HC Wainwright restated a “buy” rating and set a $68.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, November 6th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Finally, Deutsche Bank initiated coverage on shares of DENTSPLY SIRONA in a research report on Friday, December 8th. They set a “buy” rating and a $81.00 price objective for the company. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $69.15.
In other news, Director Eric Brandt sold 6,409 shares of the stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the completion of the transaction, the director now owns 12,073 shares in the company, valued at approximately $821,446.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.99% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in XRAY. Raymond James Financial Services Advisors Inc. increased its holdings in shares of DENTSPLY SIRONA by 85.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 24,432 shares of the medical instruments supplier’s stock valued at $1,584,000 after purchasing an additional 11,267 shares in the last quarter. Toronto Dominion Bank increased its holdings in DENTSPLY SIRONA by 23.8% during the 2nd quarter. Toronto Dominion Bank now owns 81,534 shares of the medical instruments supplier’s stock valued at $5,286,000 after acquiring an additional 15,680 shares in the last quarter. Lord Abbett & CO. LLC increased its holdings in DENTSPLY SIRONA by 17.6% during the 2nd quarter. Lord Abbett & CO. LLC now owns 696,865 shares of the medical instruments supplier’s stock valued at $45,185,000 after acquiring an additional 104,153 shares in the last quarter. Verde Servicos Internacionais S.A. increased its holdings in DENTSPLY SIRONA by 28.8% during the 3rd quarter. Verde Servicos Internacionais S.A. now owns 34,443 shares of the medical instruments supplier’s stock valued at $2,060,000 after acquiring an additional 7,706 shares in the last quarter. Finally, Harvey Investment Co. LLC increased its holdings in DENTSPLY SIRONA by 0.4% during the 3rd quarter. Harvey Investment Co. LLC now owns 210,927 shares of the medical instruments supplier’s stock valued at $12,616,000 after acquiring an additional 900 shares in the last quarter. Institutional investors and hedge funds own 96.05% of the company’s stock.
Shares of DENTSPLY SIRONA (NASDAQ:XRAY) traded down $0.09 during trading on Friday, reaching $58.06. 2,299,700 shares of the company’s stock were exchanged, compared to its average volume of 2,461,422. The stock has a market cap of $13,230.00, a P/E ratio of -16.57, a P/E/G ratio of 2.15 and a beta of 1.17. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $68.98.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Thursday, March 29th will be issued a $0.0875 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.60%. DENTSPLY SIRONA’s dividend payout ratio is presently -10.06%.
TRADEMARK VIOLATION WARNING: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/22/0-81-earnings-per-share-expected-for-dentsply-sirona-inc-xray-this-quarter.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.